Carbon disulfide-induced alterations of neurofilaments and calpains content in rat spinal cord

Neurochemical Research

Volumn 31, Issue 12, 2006, Pages 1491-1499

  Song, Fuyong ^a   Zhao, Xiulan ^a   Zhou, Guizhen ^a   Zhu, Yingjian ^a   Xie, Keqin ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Calpain; Carbon disulfide; Distal axonopathy; Neurofilament

Indexed keywords

CALPAIN; CARBON DISULFIDE; ISOPROTEIN; M CALPAIN; MESSENGER RNA; MU CALPAIN; NEUROFILAMENT PROTEIN; NEUROFILAMENT PROTEIN H; NEUROFILAMENT PROTEIN L; NEUROFILAMENT PROTEIN M; POLYMER; TYLOXAPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOBLOTTING; INTOXICATION; MALE; NEUROFILAMENT; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD; SUPERNATANT; ULTRACENTRIFUGATION;

ANIMALS; BODY WEIGHT; CALPAIN; CARBON DISULFIDE; ELECTROPHORESIS; IMMUNOBLOTTING; MALE; NEUROFILAMENT PROTEINS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD;

RATTUS NORVEGICUS;

EID: 33845401641     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-006-9210-z     Document Type: Article

References (45)

1. Beauchamp RO, Bus JS, Popp JA et al (1983) A critical review of the literature on carbon disulfide toxicity. Crit Rev Toxicol 11(3):169-278
2. Peters HA, Levine RL, Matthews CG et al (1982) Carbon disulfide-induced neuropsychiatric changes in grain storage workers. Am J Ind Med 3:373-391
3. Peters HA, Levine RL, Matthews CG et al (1988) Extrapyramidal and other neurological manifestations associated with carbon disulfide fumigant exposure. Arch Neurol 45:537-540
4. Chu CC, Huang CC, Chen RS et al (1995) Carbon disulfide induced polyneuropathy in viscose rayon workers. Occup Environ Med 52:404-407
5. Huang CC (2004) Carbon disulfide neurotoxicity: Taiwan experience. Acta Neurol Taiwan 13(1):3-9
6. Gottfried MR, Graham DG, Morgan M et al (1985) The morphology of carbon disulfide neurotoxicity. Neurotoxicology 6(4):89-96
7. Colombi A, Maroni M, Picchi E et al (1981) Carbon disulfide neuropathy in rats. A morphological and ultra structural study of degeneration and regeneration. Clin Toxicol 18:1463-1474
8. Sills RC, Harry GJ, Morgan DL et al (1998) Carbon disulfide neurotoxicity in rats: V. Morphology of axonal swelling in the muscular branch of the posterior tibial nerve and spinal cord. Neurotoxicology 19:117-127
9. Spencer PS, Schaumburg HH (1977) Ultrastructural studies of the dying back process: III. The evolution of experimental giant axonal degeneration. J Neuropathol Exp Neurol 36:276-299
10. Graham DG, Amarnath V, Valentine WM et al (1995) Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Crit Rev Toxicol 25(2):91-112
11. Lehning EJ, Persaud A, Dyer KR et al (1998) Biochemical and morphologic characterization of acrylamide peripheral neuropathy. Toxicol Appl Pharmacol 151(2):211-221
12. 2-mediated cross-linking of erythrocyte spectrin and neurofilament protein: dose response and temporal relationship to the formation of axonal swellings. Toxicol Appl Pharmacol 142(1):95-105
13. Valentine WM, Graham DG, Anthony DC (1993) Covalent cross-linking of erythrocyte spectrin by carbon disulfide in vivo. Toxicol Appl Pharmacol 121(1):71-77
14. LoPachin RM, He D, Reid ML (2005) 2,5-Hexanedione-induced changes in the neurofilament subunit pools of rat peripheral nerve. Neurotoxicology 26(2):229-240
15. LoPachin RM, He D, Reid ML et al (2004) 2,5-Hexanedione-induced changes in the monomeric neurofilament protein content of rat spinal cord fractions. Toxicol Appl Pharmacol 198(1):61-73
16. Zhang TL, Zhao XL, Zhu ZP et al (2005) 2,5-Hexanedione induced decrease in cytoskeletal proteins of rat sciatic-tibial nerve. Neurochem Res 30:177-183
17. Song FY, Yu SF, Zhao XL et al (2006) Carbon disulfide-induced changes in cytoskeleton protein content of rat cerebral cortex. Neurochem Res 31:71-79
18. Banik NL, Hogan EL, Powers JM et al (1982) Degradation of cytoskeletal proteins in spinal cord injury. Neurochem Res 7:1465-1475
19. Banik NL, Matzelle DC, Gantt-Wilford G et al (1997) Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res 752:301-306
20. Shields DC, Schaecher KE, Saido TC et al (1999) A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain. Proc Natl Acad Sci USA 96:11486-11491
21. Ray SK, Banik NL (2003) Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr Drug Targets CNS Neurol Disord 2:173-189
22. Guo-Ross S, Yang E, Bondy SC (1998) Elevation of cerebral proteases after systemic administration of aluminum. Neurochem Int 33(3):277-282
23. Moser VC, Phillips PM, Morgan DL et al (1998) Carbon disulfide neurotoxicity in rats: VII. Behavioral evaluations using a functional observational battery. Neurotoxicology 19(1):147-157
24. Chiu FC, Norton WT (1982) Bulk preparation of CNS cytoskeleton and the separation of individual neurofilament proteins by gel filtration: dye-binding characteristics and amino acid compositions. J Neurochem 39:1252-1260
25. Tsuda M, Tashiro T, Komiya Y (1997) Increased solubility of high molecular mass neurofilament subunit by suppression of dephosphorylation: its relation to axonal transport. J Neurochem 68:2558-2565
26. Zhang TL, Han XL, Zhao XL et al (2005) 2,5-Hexanedione induced reduction in protein content and mRNA expression of neurofilament in rat cerebral cortex. Environ Toxicol Pharmacol 20:92-98
27. Lee MK, Cleveland DW (1996) Neuronal intermediate filaments. Annu Rev Neurosci 19:187-217
28. Ching GY, Liem RK (1993) Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absences of preexisting cytoplasmic intermediate filaments. J Cell Biol 122:1323-1335
29. Lee MK, Xu Z, Wong PC et al (1993) Neurofilaments are obligate heteropolymers in vivo. J Cell Biol 122:1337-1350
30. Floyd RA (1999) Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 222:236-245
31. Hirokawa N, Terada S, Funakoshi T et al (1997) Slow axonal transport: the subunit transport model. Cell Biol 7:384-388
32. Shea TB, Dahl DC, Nixon RA et al (1997) Triton-soluble phosphovariants of the heavy neurofilament subunit in developing and mature mouse central nervous system. J Neurosci Res 48:515-523
33. Shea TB, Sihag RK, Nixon RA (1990) Dynamics of phosphorylation and assembly of the high molecular weight neurofilament subunit in NB2a/d1 neuroblastoma. J Neurochem 55:1784-1792
34. Jung C, Yabe JT, Wang FS et al (1998) Neurofilament subunits can undergo axonal transport without incorporation into Triton-insoluble structures. Cell Motil Cytoskeleton 40:44-58
35. Yabe JT, Chan WK-H, Chylinski T et al (2001) The predominant form in which neurofilament subunits undergo axonal transport varies during axonal initiation, elongation and maturation. Cell Motil Cytoskeleton 48:61-83
36. Braendgaard H, Sidenius P (1986) Anterograde components of axonal transport in motor and sensory nerves in experimental 2,5-hexanedione neuropathy. J Neurochem 47:31-37
37. Watson DF, Fittro KP, Hoffman PN et al (1991) Phosphorylation-related immunoreactivity and the rate of transport of neurofilaments in chronic 2,5-hexanedione intoxication. Brain Res 539:103-109
38. Gupta RP, Lin WW, Abou-Donia MB (1999) Enhanced mRNA expression of neurofilament subunits in the brain and spinal cord of diisopropyl phosphorofluoridate-treated hens. Biochem Pharmacol 57:1245-1251
39. Croall DE, DeMartino GN (1991) Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol Rev 71:813-847
40. Daniel KG, Anderson JS, Zhong Q et al (2003) Association of mitochondrial calpain activation with increased expression and autolysis of calpain small subunit in an early stage of apoptosis. Int J Mol Med 12:247-252
41. Glass JD, Culver DG, Levey AI et al (2002) Very early activation of m-calpain in peripheral nerve during Wallerian degeneration. J Neurol Sci 196:9-20
42. Gupta RP, Abou-Donia MB (1996) Alterations in the neutral proteinase activities of central and peripheral nervous systems of acrylamide-, carbon disulfide-, or 2,5-hexanedione-treated rats. Mol Chem Neuropathol 29:53-66
43. Ray SK, Shields DC, Saido TC et al (1999) Calpain activity and translational expression increased in spinal cord injury. Brain Res 816:375-380
44. Beaudet L, Cote F, Houle D et al (1993) Different posttranscriptional controls for the human neurofilament light and heavy genes in transgenic mice. Brain Res Mol Brain Res 18(1-2):23-31
45. Hentze MW (1994) Enzymes as RNA-binding proteins: a role for (di)nucleotide-binding domains? Trends Biochem Sci 19(3):101-103